Red Light Holland Announces Closing of Final Tranche of Fully Subscribed Private Placement Including Strategic Mutual Investment with PharmaDrug

– July 16, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to …

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

—  Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”), is pleased to announce that, further to its press release on June 10, …

Mydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to its Scientific Advisory Board

— Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”), announced today that seven-time Nobel Prize-nominated scientist Dr. Malireddy Srinivasulu Reddy …

Mydecine Innovations Group Bolsters Scientific Advisory Board Adding a Leading Neuroscientist and a Psychopharmacology Specialist

— Mydecine Innovations Group Inc. (CSE:MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”) is pleased to announce the addition of two key strategic advisors to …